Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Philogen in the news
Media Library
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Media Library
Philogen in the news
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
Webinars
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Sustainability (ESG)
News & Events
2022
,
Investors
,
Press Releases
L’Assemblea degli Azionisti ha approvato il bilancio di esercizio 2021 e la politica di remunerazione, ha nominato il nuovo Consiglio di Amministrazione e il relativo presidente per il triennio 2022-2024
Apr 27, 2022
More details
Last News & Events
May
2022
16
16 maggio 2022 – Aggiornamento sul programma di acquisto di azioni proprie
May
2022
12
The Board of Directors approves the net financial position for the first quarter of 2022
« Previous
1
…
63
64
65
66
67
…
116
Next »